Xiangqin Zheng
Biographic Data
| ID | 9995117 |
|---|---|
| NAME | Xiangqin Zheng |
| GIVEN NAMES | Xiangqin |
| FAMILY NAME | Zheng |
| SIGNATURE | ZHENG X |
| AFFILIATIONS | Fujian Medical University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Clinical and economic impacts of a clinical pathway-based single disease payment policy on hysterectomy for uterine fibroids
Objective: In 2017, China introduced clinical pathway-based single disease payment (CP-SDP) to curb healthcare costs, yet its impact is uncertain. Using uterine fibroids as a case, we evaluated its effectiveness. Methods: We analyzed 4,727 hysterectomy cases for uterine fibroids from a tertiary hospital in Fujian Province between January 2014 and December 2023. Using an interrupted time series (ITS) with August 2017 as the intervention point, we …
Decoding Fujian’s cervical HPV landscape
Background: Persistent HR-HPV causes cervical cancer, exhibiting geographic variance. Europe/Americas have higher HPV16/18 rates, while Asia/Africa predominantly have non-16/18 HR-HPV. This study in Fujian, Asia, explores non-16/18 HR-HPV infections, assessing their epidemiology and cervical lesion association for targeted prevention. Methods: A total of 101,621 women undergoing HPV screening at a hospital in Fujian Province from 2013 to 2019 wer…
No prominent works on this page.
Decoding Fujian’s cervical HPV landscape
Background: Persistent HR-HPV causes cervical cancer, exhibiting geographic variance. Europe/Americas have higher HPV16/18 rates, while Asia/Africa predominantly have non-16/18 HR-HPV. This study in Fujian, Asia, explores non-16/18 HR-HPV infections, assessing their epidemiology and cervical lesion association for targeted prevention. Methods: A total of 101,621 women undergoing HPV screening at a hospital in Fujian Province from 2013 to 2019 wer…
Clinical and economic impacts of a clinical pathway-based single disease payment policy on hysterectomy for uterine fibroids
Objective: In 2017, China introduced clinical pathway-based single disease payment (CP-SDP) to curb healthcare costs, yet its impact is uncertain. Using uterine fibroids as a case, we evaluated its effectiveness. Methods: We analyzed 4,727 hysterectomy cases for uterine fibroids from a tertiary hospital in Fujian Province between January 2014 and December 2023. Using an interrupted time series (ITS) with August 2017 as the intervention point, we …
Endometrial and Cervical Cancer Treatments (2 works) · Biology (1 work) · Cancer (1 work) · Cervical cancer (1 work) · Cervical Cancer and HPV Research (1 work) · Economic and Financial Impacts of Cancer (1 work) · Endometrial cancer (1 work) · Epidemiology (1 work) · Gene (1 work) · Genetics (1 work)